Loading...

Home
ETF
TIVC

TIVC

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TIVC News

Davis Commodities Reports $95M Revenue in H1, Up 42.1%

Dec 26 2025Benzinga

Tivic Grows Its Intellectual Property Assets

Nov 10 2025Newsfilter

Tivic Health Scheduled to Announce Third Quarter 2025 Financial Results on November 14th Through Conference Call and Webcast

Nov 06 2025Newsfilter

Tivic CEO Jennifer Ernst to Participate in Panel at Northwell Health Innovation Constellation Forum on October 23rd

Oct 22 2025Newsfilter

Live Stream Registration Now Open for Day 2 of the Emerging Growth Conference 86 on September 25

Sep 23 2025Globenewswire

Tivic Health's CEO Jennifer Ernst to Speak at Emerging Growth's Virtual Conference in September

Sep 22 2025Newsfilter

Tivic Finalizes Verification of Entolimod™ Cell Line: Initial Move Towards CGMP Manufacturing for BLA Submission

Sep 10 2025Newsfilter

Tivic Secures Two Investigational New Drug Applications for Entolimod™ Targeting Acute Radiation Syndrome (ARS) and Advanced Cancers

Aug 20 2025Newsfilter

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Aug 15 2025Newsfilter

Stocks Moving Premarket: PMNT, KULR, ENLV, ORGN, And Other Gainers & Losers

Aug 15 2025NASDAQ.COM

Tivic Health (TIVC) Q2 2025 Earnings Transcript

Aug 14 2025NASDAQ.COM

Tivic Health Sales Drop 39 Percent

Aug 14 2025NASDAQ.COM

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Jul 08 2025Newsfilter

Life Sciences Investor Forum: Now Available for Online Viewing

Jun 13 2025Newsfilter

Life Sciences Investor Forum Agenda Announced for June 11th-12th

Jun 10 2025Newsfilter

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 15 2025Newsfilter